Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Trinean Signs a Global Agreement with Bayer CropScience

Published: Wednesday, June 12, 2013
Last Updated: Wednesday, June 12, 2013
Bookmark and Share
Bayer will use Trinean’s technology for biomolecule QC using spectral content profiling.

Trinean it has entered into a long-term agreement with Bayer CropScience to supply DropSense96 and Xpose droplet readers along with its proprietary cDrop spectral analysis software to Bayer CropScience's global operations. Bayer CropScience will be using Trineans technology for High Throughput quantification and quality control of isolated biomolecules to assure robust outcome of genetic tests in its molecular breeding program.

“Trinean is delighted to be a global supplier to Bayer CropScience. Our microfluidic technology matches the expectations of Bayer CropScience in terms of automation, minimal sample consumption and accurate quantification of a broad range of plant extracts.” said Yvan Sergeant, VP commercial operations of Trinean. “We are committed to helping Bayer CropScience reach its high standards in the genetic research and high-quality seeds for field and vegetable crops.”

A real challenge exists for all plant genetic labs to accurately quantify nucleic acid extracts from plant tissue due to variations in genome size and the presence of co-purified buffer components or plant metabolites influencing both the quantification result as well as downstream genetic tests. Unlike traditional methods, the Trinean technology performs an in-depth sample content analysis by profiling the measured UV/VIS absorbance spectrum for both the biomolecule of interest and interfering chemicals. This approach allows specific concentration determination and genuine purity analysis within a simple ‘drop & read’ approach.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Fly Study into Therapies for HVP-Induced Cancer
Fruit flies may help scientists understand the mechanism by which HPV can cause cancer as well as identify potential drug treatments.
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
'Missing Evolutionary Link' of Natural Drug Source Found
Scripps Florida study finds 'missing evolutionary link' of a widely used natural drug source
Grad Student's Finding Enables Rapid Compound Screening
Grad student makes technical leap that could enable rapid screening of anti-cancer compounds.
Uncovering Constructor Proteins
Scientists have discovered a new bacterial cell wall builder that could be a target for antibiotic development.
Cholesterol Linked to Aggressive Cancers
Research suggests fats, such as cholesterol, can increase aggressive cancer progression.
Biomarker Breakthrough Could Improve Parkinson’s Treatment
A new method of tracking Parkinson's progression could aid evaluation of new and experimental treatments to slow or stop the disease.
Targeting Neglected Diseases
New enzyme-mapping advancement could help drug development for combating diseases in the developing world.
How Parkinson’s Disease Alters Brain Activity Over Time
The NIH study provides a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!